Pharmacotherapy for Generalized Anxiety Disorder: A Case Study
This paper presents a three-decision pharmacotherapy case study for a hypothetical 46-year-old male patient (Client X) diagnosed with generalized anxiety disorder (GAD). Beginning with a Hamilton Anxiety Scale score of 26, the case traces the rationale for initiating Paxil (paroxetine) at 10 mg, maintaining the dose after initial symptom improvement, and ultimately increasing the dose when progress plateaued. Each decision is grounded in current evidence on SSRI efficacy and safety, patient-specific factors such as hypertension and occupational demands, and ethical principles including fidelity, nonmaleficence, and autonomy. The paper concludes with a recommendation to augment pharmacotherapy with cognitive behavioral therapy (CBT) for improved outcomes.
- Introduction: Patient profile, GAD symptoms, and assessment context
- Decision #1: Begin Paxil 10 mg PO Daily: Rationale for starting SSRI at low dose
- Decision #2: No Change in Drug or Dose: Maintaining dose after partial symptom improvement
- Decision #3: Increase Drug to 75 mg PO Daily: Dose escalation after plateau in symptom relief
- Conclusion: Treatment summary and CBT augmentation recommendation
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- Each clinical decision is paired with a clear rationale drawn from peer-reviewed sources, making the argument traceable and evidence-based rather than opinion-driven.
- The paper consistently links pharmacological choices to patient-specific factors (hypertension, occupation, HAM-A scores), demonstrating individualized clinical reasoning.
- Ethical principles (fidelity, nonmaleficence, autonomy) are woven into each decision section rather than treated as an afterthought, showing integration of professional ethics with clinical practice.
Key academic technique demonstrated
The paper uses a sequential decision-point structure to simulate clinical reasoning across time, allowing the writer to justify not only what was chosen but also what was explicitly rejected and why. This technique of comparative justification — explaining why alternatives such as buspirone, tricyclic antidepressants, and SNRIs were ruled out — strengthens each decision's credibility and reflects real-world prescribing logic.
Structure breakdown
The paper follows a five-part structure: an introduction establishing the patient profile and assessment context; three body sections each devoted to a distinct clinical decision with rationale, expected outcomes, and an ethical consideration; and a conclusion that synthesizes the treatment arc and recommends adjunctive CBT. This decision-by-decision scaffolding keeps the argument focused and mirrors the format of clinical case documentation.
Introduction
Most people experience anxiety at some point in their lives. However, anxiety may be deemed abnormal or unusual when it is not only frequent but also excessive or intense. Client X (a hypothetical name), a 46-year-old white male, presents with symptoms consistent with generalized anxiety disorder (GAD). He has been referred by his primary care physician following an emergency room visit during which he complained of shortness of breath, chest tightness, and a feeling of "impending doom." At the time of assessment, Client X indicates that he still experiences shortness of breath and chest tightness, and that the "impending doom" feeling occurs on an intermittent basis. He also reports frequent alcohol use as a coping mechanism for these symptoms. Results from the Hamilton Anxiety Scale (HAM-A) return a score of 26, which is interpreted as moderate to severe anxiety.
There are a number of patient factors to consider when determining the most appropriate pharmacological intervention. These factors include the patient's age, occupation, and socioeconomic status. It is also important to establish whether the patient is currently taking any other medications and whether he has previously been diagnosed with any psychiatric disorder or chronic illness. There is further need to determine whether Client X has any comorbid psychiatric conditions at this time. The relevance of these factors cannot be overstated, particularly with respect to minimizing the probability of side effects and enhancing patient convenience — a consideration that past studies have identified as crucial to promoting adherence to the treatment regimen.
Create your account
Always verify citation format against your institution’s current style guide requirements.